Unravelling the Mechanism of Action of Myristica Sebifera 12c: Integrating Lc-Ms, in Silico Analysis, and in Vitro Assays

23 Pages Posted: 21 Nov 2024

See all articles by KUMARAVEL V

KUMARAVEL V

National Institute of Homoeopathy

Kuntal Das

National Institute of Homoeopathy

Niharika Shaw

National Institute of Homoeopathy

Subhrajit Pal

National Institute of Homoeopathy

Rumsha Tamkeen

National Institute of Homoeopathy

Syed Afsar Ali

National Institute of Homoeopathy

Pratima Pal

National Institute of Homoeopathy

Abstract

Background: Medicinal plants are extensively used in traditional and complementary medicine to treat various human diseases. Microbes are currently the largest threat to mankind, causing 1.27 million global deaths in 2019 due to drug resistance. Myristica sebifera (MS), from the Myristicaceae family, is known for its antiseptic properties, inflammation, sepsis, and suppuration.Purpose: In-silico and in-vitro are lacking in homeopathy. This study was done to establish their mode of action in the human body.Study design: This study identified compounds in Myristica sebifera 12C (MS12C) using LC-MS, in silico and in vitro studies to explore its medicinal properties.Materials and methods: Phytoconstituents of MS12C were analysed using LC-MS, Cytoscape 3.10.2, webgestalt, PyRx Software for molecular docking, and validated through in vitro studies using egg albumin and antibiofilm assays.Results: The bioactive components, 7-methoxycoumarin, N-methyltryptamine, and dimethyltryptamine, were identified. Cytoscape and GO enrichment analysis suggested S1003, KDR, PTPRC, MPO, NOS2, MMP9, EGFR, and HTRIA as key targets. Molecular docking showed a strong binding affinity (>7.7 kcal/mol) against the Matrix metalloproteinase-9 (MMP9) protein gene. The in vitro egg albumin assay demonstrated 64.70% inhibition of protein denaturation. The Crystal violet assay shows, thinner biofilm layers than those in the controls and has highest inhibitory percentage (55.57%) at 30µl.Conclusion: MS12C acts on the MMP9 target gene, confirmed through in vitro studies by inhibiting protein denaturation and thin biofilm formation. Hence, MS12C, a potential therapeutic agent, has emerged as a natural MMP 9 inhibitor for various inflammatory, septic, and suppurative drug-resistant disorders.

Keywords: Myristica sebifera 12C, Inflammation, Sepsis, Suppuration, Molecular Docking, Gene Targets, Bio-film assay, Egg albumin assay

Suggested Citation

V, KUMARAVEL and Das, Kuntal and Shaw, Niharika and Pal, Subhrajit and Tamkeen, Rumsha and Ali, Syed Afsar and Pal, Pratima, Unravelling the Mechanism of Action of Myristica Sebifera 12c: Integrating Lc-Ms, in Silico Analysis, and in Vitro Assays. Available at SSRN: https://ssrn.com/abstract=5028126 or http://dx.doi.org/10.2139/ssrn.5028126

Kumaravel V (Contact Author)

National Institute of Homoeopathy ( email )

India
9748163274 (Phone)

Kuntal Das

National Institute of Homoeopathy ( email )

India

Niharika Shaw

National Institute of Homoeopathy ( email )

India

Subhrajit Pal

National Institute of Homoeopathy ( email )

India

Rumsha Tamkeen

National Institute of Homoeopathy ( email )

India

Syed Afsar Ali

National Institute of Homoeopathy ( email )

India

Pratima Pal

National Institute of Homoeopathy ( email )

India

Do you have a job opening that you would like to promote on SSRN?

Paper statistics

Downloads
155
Abstract Views
1,286
Rank
482,968
PlumX Metrics